GILD — Gilead Sciences, Inc.

Healthcare · Drug Manufacturers - General · NASDAQ

$134.47

Market Cap: $167.0B

Key Fundamentals

P/E Ratio

19.6

P/B Ratio

7.1

Return on Equity

42.2%

Net Profit Margin

28.6%

Revenue Growth

2.4%

Dividend Yield

2.4%

Debt / Equity

0.9

EPS (TTM)

$6.86

Piotroski F-Score

9/9

Beta

0.33

About Gilead Sciences, Inc.

Gilead Sciences, Inc. (ticker: GILD, listed on NASDAQ) is a company in the Healthcare · Drug Manufacturers - General sector with a market capitalization of $167.0B.

This page shows publicly available fundamental data for GILD sourced from Valory's database of 36,000+ US stocks. For deeper analysis — including Valory Formula projected returns, historical financials, and analyst consensus — create a free account.

Data is updated regularly during US market hours. Fundamental data is sourced from public filings and market data providers. This page is for informational purposes only and does not constitute investment advice.